Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2021-02-12 4:48 pm Sale | 13G | ADAMAS PHARMACEUTICALS INC ADMS | Stonepine Capital Management LLC | 808,431 2.8% | -1,432,808 (-63.93%) | View |
2021-02-12 4:43 pm Purchase | 13G | APOLLO ENDOSURGERY INC APEN | Stonepine Capital Management LLC | 2,603,480 9.99% | 462,201 (+21.59%) | View |
2021-02-12 4:37 pm Purchase | 13G | AMRYT PHARMA PLC SPONSORED ADR AMYT | Stonepine Capital Management LLC | 11,082,415 6.2% | 11,082,415 (New Position) | View |
2021-02-12 4:26 pm Purchase | 13G | CTI BIOPHARMA CORP CTIC | Stonepine Capital Management LLC | 8,148,420 9.99% | 4,534,820 (+125.49%) | View |
2021-02-05 6:39 pm Purchase | 13G | APPLIED GENETIC TECHNOLOGIES C AGTC | Stonepine Capital Management LLC | 2,273,876 5.2% | 2,273,876 (New Position) | View |
2020-12-23 5:12 pm Purchase | 13G | SCYNEXIS INC SCYX | Stonepine Capital Management LLC | 1,536,953 7.7% | 1,536,953 (New Position) | View |
2020-12-16 6:02 pm Purchase | 13G | AYTU BIOPHARMA INC AYTU | Stonepine Capital Management LLC | 1,333,334 7.7% | 1,333,334 (New Position) | View |
2020-09-11 4:34 pm Purchase | 13G | INTERPACE BIOSCIENCES INC IDXG | Stonepine Capital Management LLC | 277,277 6.9% | 169,517 (+157.31%) | View |
2020-08-05 4:09 pm Unchanged | 13G | CATALYST BIOSCIENCES INC N CBIO | Stonepine Capital Management LLC | 1,039,235 6% | 0 (Unchanged) | View |
2020-04-17 4:36 pm Purchase | 13G | INTERPACE BIOSCIENCES INC IDXG | Stonepine Capital Management LLC | 107,760 2.7% | 107,760 (New Position) | View |
2020-04-02 4:43 pm Purchase | 13G | BAUDAX BIO INC BXRX | Stonepine Capital Management LLC | 1,819,849 9.99% | 1,819,849 (New Position) | View |
2020-03-12 4:58 pm Purchase | 13G | CATALYST BIOSCIENCES INC N CBIO | Stonepine Capital Management LLC | 1,039,235 6% | 1,039,235 (New Position) | View |
2020-02-21 4:47 pm Purchase | 13G | CIDARA THERAPEUTICS INC CDTX | Stonepine Capital Management LLC | 2,054,048 5% | 2,054,048 (New Position) | View |
2020-02-13 5:03 pm Purchase | 13G | IVERIC BIO INC ISEE | Stonepine Capital Management LLC | 5,147,744 9.99% | 5,147,744 (New Position) | View |
2020-02-13 4:52 pm Sale | 13G | OPIANT PHARMACEUTICALS INC OPNT | Stonepine Capital Management LLC | 334,272 8.2% | -23,688 (-6.62%) | View |
2020-02-13 4:50 pm Purchase | 13G | NOVELION THERAPEUTICS INC NVLN | Stonepine Capital Management LLC | 3,909,207 19.9% | 205,787 (+5.56%) | View |
2020-02-13 4:47 pm Purchase | 13G | NEOS THERAPEUTICS INC NEOS | Stonepine Capital Management LLC | 4,858,889 9.8% | 648,736 (+15.41%) | View |
2020-02-13 4:36 pm Purchase | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGM | Stonepine Capital Management LLC | 5,913,812 9.99% | 3,237,923 (+121.00%) | View |
2020-02-13 4:34 pm Sale | 13G | CUMBERLAND PHARMACEUTICALS INC CPIX | Stonepine Capital Management LLC | 896,170 5.9% | -417,259 (-31.77%) | View |
2020-02-13 4:32 pm Sale | 13G | CTI BIOPHARMA CORP CTIC | Stonepine Capital Management LLC | 3,613,600 6.2% | -2,112,979 (-36.90%) | View |